(Q37203618)

18 August 2017

title

A review of normal sleep and its disturbances in Parkinson's disease (English)

1 reference

18 August 2017

1 reference

Pal PK

1

1 reference

18 August 2017

Calne S

series ordinal

2

1 reference

18 August 2017

Samii A

series ordinal

3

1 reference

18 August 2017

Fleming JA

series ordinal

4

1 reference

18 August 2017

publication date

1 April 1999

1 reference

18 August 2017

number of pages

17

1 reference

Parkinsonism and Related Disorders

inferred from page(s)

published in

1 reference

18 August 2017

volume

5

1 reference

18 August 2017

issue

1-2

1 reference

18 August 2017

page(s)

1-17

1 reference

Sleep in normal aging and dementia.

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Circadian temperature rhythms in young adult and aged men.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Chronobiology of aging: temperature, sleep-wake rhythms and entrainment.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Local cerebral glucose utilization in non-rapid eye movement sleep.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Hypnogenic center theory of sleep: no support from metabolic mapping in monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Diminished brain glucose metabolism is a significant determinant for falling rates of systemic glucose utilization during sleep in normal humans

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Human puberty - simultaneous augmented secretion of luteinizing hormone and testosterone during sleep

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

The nocturnal rise of human prolactin is dependent on sleep

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Growth hormone secretion during sleep

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Protein synthesis, bodily renewal and the sleep-wake cycle

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Positive correlations between cerebral protein synthesis rates and deep sleep in Macaca mulatta.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Rates of cerebral protein synthesis are linked to slow wave sleep in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Changes in sleep cycle patterns with age

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Ontogenetic development of the human sleep-dream cycle

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Dependence on REM sleep of overnight improvement of a perceptual skill

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

The function of dream sleep

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

“It's Time, You Must Wake up Now”

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Suprachiasmatic nuclei lesions eliminate circadian temperature and sleep rhythms in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

The suprachiasmatic nuclei: two circadian clocks?

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Reversible suppression of ponto-geniculo-occipital waves by localized cooling during paradoxical sleep in cats

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Effects of ponto-mesencephalic lesions and electrical stimulation upon PGO waves and EMPs in unanesthetized cats

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

The effect of lateral geniculate lesions on phasic electrical activity of the cortex during desynchronized sleep in the cat

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Sleep cycle oscillation: reciprocal discharge by two brainstem neuronal groups.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Sleep disruption in the course of chronic levodopa therapy: an early feature of the levodopa psychosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Sleep, excessive daytime sleepiness and fatigue in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Head tremor after a remission of spasmodic torticollis

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Sleep disturbances in Parkinson's disease patients and spouses.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Sleep in older women with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Sleep in Parkinson's disease. The role of depression and anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Dream phenomena induced by chronic levodopa therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Levodopa-induced psychosis: a kindling phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Polysomnographic sleep measures in Parkinson's disease patients with treatment-induced hallucinations.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Incidental Lewy body disease in a patient with REM sleep behavior disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Lewy body disease in a patient with REM sleep disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Probable diffuse Lewy body disease presenting as REM sleep behavior disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Sleepiness in different situations measured by the Epworth Sleepiness Scale.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Daytime sleepiness, snoring, and obstructive sleep apnea. The Epworth Sleepiness Scale.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Correlates of daytime sleepiness in 4578 elderly persons: the Cardiovascular Health Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Evaluation of excessive daytime sleepiness in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Fatigue and melatonin in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Differences in sleep in patients with parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Observations on parkinsonian tremor in all-night sleep

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

The parkinsonian tremor in sleep

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

The Effect of Sleep on the Dyskinetic Movements of Parkinson's Disease, Gilles de la Tourette Syndrome, Huntington's Disease, and Torsion Dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Parkinsonian tremor loses its alternating aspect during non-REM sleep and is inhibited by REM sleep

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

1 reference

7 January 2021

[Influence of L-DOPA on night sleep in parkinsonian patients]

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Levodopa-induced myoclonus

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Periodic Limb M[ovements in Sleep in Community-Dwelling Elderly

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Nocturnal myoclonus syndrome (periodic movements in sleep) related to central dopamine D2-receptor alteration.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Nocturnal akathisia in Parkinson's disease: treatment with clozapine.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Akathisia in idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Sleep disruption in Parkinson's disease. Assessment by continuous activity monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Pulmonary function in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Involvement of upper-airway muscles in extrapyramidal disorders. A cause of airflow limitation

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Swallowing abnormalities and their response to treatment in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Respiration and sleep in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Respiration and sleep in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Respiration and sleep in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Self-assessed cognitive function in snorers and sleep apneics. An epidemiological study of 1,504 females and males aged 30-60 years: the Dan-MONICA II Study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Self-reported depressive symptomatology, mood ratings, and treatment outcome in sleep disorders patients

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

A longitudinal study of depressed mood and sleep disturbances in elderly adults

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Interval between onset of sleep and rapid-eye-movement sleep as an indicator of depression

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Preliminary examination of the comorbidity of anxiety and depression in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

The pattern of depressive symptoms varies with progression of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Sleep EEG in depressed and nondepressed patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Sleep disorders, pain, and depression in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Evidence for a widespread dopaminergic innervation of the human cerebral neocortex

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Synchronization of the EEG and sedation induced by neuroleptics depend upon blockade of both D1 and D2 dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Stimulation of dopamine D-1 receptors by SKF 38393 induces EEG desynchronization and behavioral arousal

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

The dopamine D1 receptor is involved in the regulation of REM sleep in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

The D1 dopamine receptor antagonist SCH 23390 enhances REM sleep in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Brain dopamine receptors and sleep in the rat: Effects of stimulation and blockade

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Dopaminergic transmission and the sleep-wakefulness continuum in man.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Effect of L-dopa on the sleep of man.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Reversal of sleep disturbance in Parkinson's disease by antiparkinsonian therapy: a preliminary study.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Madopar HBS in Parkinson patients with nocturnal akinesia

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Parkinson's disease in the elderly: response to and optimal spacing of night time dosing with levodopa

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

A sustained-release formulation of L-dopa (Madopar HBS) in the treatment of nocturnal and early-morning disabilities in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Five years' treatment of Parkinson's disease with levodopa. Therapeutic results and survival of 100 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Effect of pharmacologic treatments on the sleep of depressed patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Dose dependent inhibition of REM sleep in normal volunteers by biperiden, a muscarinic antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Experimental acceleration and slowing of REM sleep ultradian rhythm by cholinergic agonist and antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Clinical correlates of sleep benefit in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Sleep benefit in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

The on-off effect in Parkinson's disease treated with levodopa with remarks concerning the effect of sleep

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

A clinical, pharmacologic, and polysomnographic study of sleep benefit in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Sleep in patients with Parkinson's disease and normal subjects prior to and following levodopa administration

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Treating psychophysiologic insomnia with biofeedback.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Chronotherapy: resetting the circadian clocks of patients with delayed sleep phase insomnia

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Bright light induction of strong (type 0) resetting of the human circadian pacemaker

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Sleep disorders in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Suppression of REM rebound by Pergolide

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Gabapentin for parkinsonism: a double-blind, placebo-controlled, crossover trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Gabapentin and motor fluctuations in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Gabapentin augments whole blood serotonin in healthy young men

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Management of insomnia

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Defining benzodiazepine dependence: The confusion persists.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

A double-blind, comparative study of zolpidem and placebo in the treatment of insomnia in elderly psychiatric in-patients

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

The effects of acute and repeated doses of zolpidem on subjective sleep, psychomotor performance and cognitive function in elderly volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Zolpidem in insomnia: a 3-year post-marketing surveillance study in Switzerland.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Zolpidem and rebound insomnia--a double-blind, controlled polysomnographic study in chronic insomniac patients

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Zolpidem for dementia-related insomnia and nighttime wandering

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Zolpidem: distinct from triazolam?

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Zopiclone: is there any dependence and abuse potential?

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Zopiclone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy as an hypnotic

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Parkinson's disease, depression, and ECT: a review and case study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

1 reference

7 January 2021

Managing the late complications of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Clozapine in the treatment of psychosis in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Clozapine treatment of parkinsonism with psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Low-dose clozapine in the treatment of levodopa-induced mental disturbances in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Low dose of clozapine in the treatment of dopaminergic psychosis in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Clozapine in the treatment of parkinsonian patients with dopaminomimetic psychosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Psychosis in advanced Parkinson's disease: treatment with ondansetron, a 5-HT3 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Ondansetron for hallucinosis in advanced Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Successful treatment of restless legs with clonazepam

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

The use of triazolam in older patients with periodic leg movements, fragmented sleep, and daytime sleepiness.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Treatment of the restless legs syndrome with clonazepam

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Nocturnal myoclonus: treatment efficacy of clonazepam and temazepam.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Clonazepam treatment of insomnia due to sleep myoclonus

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Treatment of restless legs syndrome and periodic movements during sleep with L-dopa: a double-blind, controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Dyskinesias while awake and periodic movements in sleep in restless legs syndrome: treatment with opioids

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Response to opioids in three patients with restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Effectiveness of clonidine in alleviating the symptoms of "restless legs"

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Clonidine in the treatment of "restless leg" syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

Effect of baclofen on sleep-related periodic leg movements.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900011-5

7 January 2021

10.1016/S1353-8020(99)00011-5

Identifiers

DOI

1 reference

18 August 2017

1 reference